Загрузка...
Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
The peripheral T-cell lymphomas are a rare and heterogeneous group of mature T-cell lymphomas with limited available therapies. The outcome of frontline chemotherapy regimens has been disappointing, with a long-term survival of only 20%–30%. There is an urgent need to optimize induction therapy by i...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4216035/ https://ncbi.nlm.nih.gov/pubmed/25368524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S59269 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|